Skip to main content
. 2020 Nov 21;11(9):2719–2725. doi: 10.1016/j.apsb.2020.11.011

Figure 3.

Figure 3

(A) In vitro pAkt assay comparing the bioactivity of native insulin and Ins-SA-Alb (native insulin EC50 = 2.126 nmol/L, Ins-SA-Alb EC50 = 30.32 nmol/L). (B) In vivo effects of Ins-SA-Alb and native insulin in STZ treated mice. Data were represented as mean ± SD, n = 4.